Name: Pharmaceutical Intermediates Market Size, Share, Industry, Forecast and outlook (2024-2031)
Brand: DataM Intelligence
SKU: PH2802
Price: 4350 USD
Availability: InStock

Pharmaceutical Intermediates Market Size, Share and Report 2024-2031

Pharmaceutical Intermediates Market Size, Share, Industry, Forecast and outlook (2024-2031)

<h2>Global Pharmaceutical Intermediates Market is segmented&nbsp;By Type (Chemical Intermediate, Bulk Drug Intermediate (Chiral Intermediates, Achiral Intermediates), Custom Intermediates, Others),&nbsp;By Application (Analgesics, Anti-Infective Drugs, Cardiovascular Drugs, Oral Antidiabetic Drugs, Antimicrobial Drugs, Others),&nbsp;By End-User (Biotech and Pharma Companies, Research Institutions, Contract manufacturing organizations, Others),&nbsp;and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) &ndash; Share, Size, Outlook, and Opportunity Analysis, 2024-2031</h2>

&nbsp;

<h3>Report&nbsp;Overview</h3>

<blockquote>
The Global &quot;Pharmaceutical Intermediates Market&quot;&nbsp;is estimated to reach at a CAGR&nbsp;of 4% during the forecast period (2024-2031).&nbsp;
</blockquote>

Pharmaceutical intermediates are the synthetic aggravates that are the building squares utilized in the generation of dynamic pharmaceutical fixings. Pharmaceutical intermediates are created amid the way toward assembling or amalgamation of dynamic pharmaceutical fixings. These pharmaceutical intermediates additionally experience sub-atomic changes and preparation before turning into a functioning pharmaceutical fixing.

&nbsp;

<h3>Pharmaceutical Intermediates Market Dynamics</h3>

The global pharmaceutical intermediates market growth is driven by the increasing use of pharmaceutical intermediates in the fundamental base part of active pharmaceutical ingredients (APIs), the market is also expected to witness an upsurge in demand in the forecast period.

Increasing Prevalence of Chronic Diseases is expected to drive the growth in the forecast period

The rapidly increasing prevalence of chronic diseases and the growth of the aging population across the world are among factors that are expected to increase the need for drug formulations for the management of chronic diseases. For instance, according to the World Health Organization (WHO), the prevalence of diabetes has surged from 108.0 million in 1980 to 422.0 million in 2014, and the number is rising rapidly.

Furthermore, according to the World Health Organization (WHO), the prevalence of chronic diseases is expected to increase by 57.0% by 2020, which indicates that a significant percentage of the population is suffering from chronic diseases. These factors are driving the growth of the market in the forecast period.

Increasing investments in manufacturing expected to drive the market growth

Leading pharmaceutical companies in the pharmaceutical intermediates market have announced their intentions to invest in manufacturing facilities due to various reasons such as to enhance the production capacity of pharmaceutical intermediates, reduce the corporate tax rate and increase their global footprints as well as their presence in emerging markets.

For instance, in July 2018, Pfizer invest around US$ 465.0 million to build a sterile injectable plant in Portage, Michigan. This step is a part of its announcement that it had made earlier in 2018 about its plans to invest around US$ 5.0 billion in a U.S.-based capital project due to the recent corporate tax reforms in the country. These factors are driving the growth of the market in the forecast period.

Regulatory obstruction is likely to hinder the market growth

However, the rising monetary pressure, as well as the regulatory obstruction, is expected to freeze the growth of the pharmaceutical intermediates market in the forecast period.

<h3>COVID-19 Impact Analysis</h3>

The disruptive effects of the coronavirus COVID-19 have placed enormous strain on the global supply of pharmaceutical intermediates, increasing the risk of shortages. Although production across various industries and regions in China has been gradually resuming since late February, U.S. pharmaceutical intermediates manufacturers, which heavily source directly and indirectly from China, are now exposed to high risks in supply shortages over the next one to two months. These risks are due primarily to limited operational capacity in China and how resumption of production will be prioritized. These factors are restraining the growth of the market in the forecast period.

<h3>Pharmaceutical Intermediates Market Segment Analysis</h3>

The cardiovascular drugs segment is expected to grow at the fastest CAGR during the forecast period (2021-2028)

Cardiovascular diseases are the leading cause of death worldwide. According to the American College of Cardiology, cardiovascular disease (CVD) accounted for 800,000 deaths in the United States in 2017 alone. Among Americans, an average of one person dies from cardiovascular disease, every 40 seconds. Coronary heart disease (CHD) accounts for the majority of CVD deaths, followed by stroke and heart failure. According to the European Heart Network, every year, cardiovascular disease (CVD) causes 3.9 million deaths in Europe and over 1.8 million deaths in the European Union (EU).&nbsp;

This high prevalence of cardiovascular diseases is generating a huge demand for cardiovascular drugs, which, in turn, is expected to propel the growth in the need for various pharmaceutical intermediates. Hence, owing to the aforementioned factors, the concerned segment of the pharmaceutical intermediates market and expected to grow over the forecast period.

The analgesics segment has had positive market growth in the forecast period. Analgesics, or painkillers, are used to reduce and treat aches and pains. Internal and external analgesics are used to combat pain resulting from inflammation, cancer treatments, physiological injury, neuropathic conditions, surgeries, wounds, and phantom aches. The most prominent therapeutic classes of analgesics are local anaesthesia, nonsteroidal anti-inflammatory drugs (NSAIDs), and opioids. The growing incidence of cancer worldwide and the rise in chronic diseases are mainly responsible for the consistent growth of the global analgesics market. In 2017, between 950-1000 million people were over the age of 60. However, by 2050, these numbers are expected to reach 2100 million, accounting for around 21% of the total global population. As older adults are more vulnerable to chronic and lifestyles diseases, it will significantly contribute to the sales of analgesics. Apart from this, many leading pharmaceutical companies are continually focusing on clinical advancements in both the delivery and design of analgesic drugs. They are also developing safer opioids with improved side effect profiles and effective pain relief. Moreover, the presence of a strong drug pipeline with efficacious drugs waiting for approvals by the United States Food and Drug Administration (USFDA) is further expected to enhance the use of analgesics across the globe.&nbsp;

&nbsp;

<h3>Pharmaceutical Intermediates Market Geographical Share</h3>

North America region holds the largest market share global pharmaceutical intermediates market

North America region is dominating the global pharmaceutical intermediates market accounted for the largest market share in 2020, due to the advanced research and development facilities mainly across the United States and Canada. In addition, the rising prevalence of various chronic conditions is also driving market growth across the region. The U.S. holds the largest market for H1N1 vaccination, followed by Canada. For instance, in December 2019, NACI (National Advisory Committee on Immunization) published scientific information and recommendation on MenB-fHBP (bivalent factor-H binding protein meningococcal serogroup B) vaccine (Trumenba). The presence of a strong pipeline of meningococcal vaccines is expected to maintain a significant market share in the region.

According to the 2017 report of Health Library, cardiovascular disease, listed as the underlying cause of death, accounts for nearly 801,000 deaths in the US. That is about 1 of every 3 deaths in the US. About 2,200 Americans die of cardiovascular disease each day, an average of 1 death every 40 seconds.

&nbsp;

<h3>Competitive Landscape</h3>

The Pharmaceutical Intermediates is moderately competitive with the presence of local as well as global companies. &nbsp;Some of the key players which are contributing to the growth of the market include Aceto Corporation, BASF SE, Chiracon GmbH, Yin-sheng Biotech Co., Ltd., Dishman Group, Green Vision Life Sciences, Midas Pharma GmbH, Sanofi SA, Vertellus Holdings LLC., among others. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the pharmaceutical intermediates market globally. &nbsp;&nbsp;&nbsp;

<h3>Companies to Watch &nbsp;</h3>

Sanofi S.A

Overview: Sanofi is a healthcare company, focused on patient needs and engaged in the research, development, manufacture and marketing of therapeutic solutions. Its segments are Pharmaceuticals, Human Vaccines (Vaccines), and Others. The Pharmaceuticals segment comprises the commercial operations of various franchises, including Specialty Care (Rare Diseases, Multiple Sclerosis, and Oncology), Diabetes and Cardiovascular, Established Prescription Products, Consumer Healthcare and Generics, and research and development, production and marketing activities for all of the Company&#39;s pharmaceuticals operations.

Product Portfolio: The Company&rsquo;s portfolio is comprised of drugs, generic medicines, food supplements, cosmetics, and medical devices such as cancer, cardiology, gynecology, and diabetes.

<ol>
	<li>
	Methodology and Scope

	<ol>
		<li>
		Research Methodology
		</li>
		<li>
		Research Objective and Scope of the Report
		</li>
	</ol>
	</li>
	<li>
	Market Definition and Overview
	</li>
	<li>
	Executive Summary

	<ol>
		<li>
		Market Snippet by &nbsp;Type
		</li>
		<li>
		Market snippet by Application
		</li>
		<li>
		Market Snippet by End-User
		</li>
		<li>
		Market Snippet by Region
		</li>
	</ol>
	</li>
	<li>
	Market Dynamics

	<ol>
		<li>
		Market Impacting Factors

		<ol>
			<li>
			Drivers

			<ol>
				<li>
				Increasing Prevalence of Chronic Diseases
				</li>
				<li>
				Growing R&amp;D Initiatives and Activities in the Pharmaceutical Industry
				</li>
			</ol>
			</li>
			<li>
			Restraints:

			<ol>
				<li>
				Stringent Regulatory Issues Regarding Certain Pharmaceutical Intermediate Substances
				</li>
			</ol>
			</li>
			<li>
			Opportunity
			</li>
			<li>
			Impact Analysis
			</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	Industry Analysis

	<ol>
		<li>
		Porter&#39;s Five Forces Analysis
		</li>
		<li>
		Supply Chain Analysis
		</li>
		<li>
		Pricing Analysis
		</li>
		<li>
		Regulatory Analysis
		</li>
		<li>
		Reimbursement Analysis
		</li>
		<li>
		Unmet Needs
		</li>
	</ol>
	</li>
	<li>
	COVID-19 Analysis

	<ol>
		<li>
		Analysis of Covid-19 on the Market

		<ol>
			<li>
			Before COVID-19 Market Scenario
			</li>
			<li>
			Present COVID-19 Market Scenario
			</li>
			<li>
			After COVID-19 or Future Scenario
			</li>
		</ol>
		</li>
		<li>
		Pricing Dynamics Amid Covid-19
		</li>
		<li>
		Demand-Supply Spectrum
		</li>
		<li>
		Government Initiatives Related to the Market During Pandemic
		</li>
		<li>
		Manufacturers Strategic Initiatives
		</li>
		<li>
		Conclusion&nbsp;
		</li>
	</ol>
	</li>
	<li>
	By Type

	<ol>
		<li>
		Introduction

		<ol>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
			</li>
			<li>
			Market Attractiveness Index, By Type Segment
			</li>
		</ol>
		</li>
		<li>
		Chemical Intermediate*

		<ol>
			<li>
			Introduction
			</li>
			<li>
			Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
			</li>
		</ol>
		</li>
		<li>
		Bulk Drug Intermediate

		<ol>
			<li>
			&nbsp;Chiral Intermediates
			</li>
			<li>
			Achiral Intermediates
			</li>
		</ol>
		</li>
		<li>
		Custom Intermediates
		</li>
		<li>
		Others
		</li>
	</ol>
	</li>
	<li>
	By Application

	<ol>
		<li>
		Introduction

		<ol>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
			</li>
			<li>
			Market Attractiveness Index, By Application
			</li>
		</ol>
		</li>
		<li>
		Analgesics *

		<ol>
			<li>
			Introduction
			</li>
			<li>
			Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
			</li>
		</ol>
		</li>
		<li>
		Anti-Infective Drugs
		</li>
		<li>
		Cardiovascular Drugs
		</li>
		<li>
		Oral Antidiabetic Drugs
		</li>
		<li>
		Antimicrobial Drugs
		</li>
		<li>
		Others
		</li>
	</ol>
	</li>
	<li>
	By End-User

	<ol>
		<li>
		Introduction

		<ol>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User Segment
			</li>
			<li>
			Market Attractiveness Index, By End-User Segment
			</li>
		</ol>
		</li>
		<li>
		Biotech and Pharma Companies *

		<ol>
			<li>
			Introduction
			</li>
			<li>
			Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
			</li>
		</ol>
		</li>
		<li>
		Research Institutions
		</li>
		<li>
		Contract manufacturing organizations
		</li>
		<li>
		Others
		</li>
	</ol>
	</li>
	<li>
	By Region

	<ol>
		<li>
		Introduction

		<ol>
			<li>
			Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028, By Region
			</li>
			<li>
			Market Attractiveness Index, By Region
			</li>
		</ol>
		</li>
		<li>
		North America

		<ol>
			<li>
			Introduction
			</li>
			<li>
			Key Region-Specific Dynamics
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

			<ol>
				<li>
				U.S.
				</li>
				<li>
				Canada
				</li>
				<li>
				Mexico
				</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>
		Europe

		<ol>
			<li>
			Introduction
			</li>
			<li>
			Key Region-Specific Dynamics
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

			<ol>
				<li>
				Germany
				</li>
				<li>
				U.K.
				</li>
				<li>
				France
				</li>
				<li>
				Italy
				</li>
				<li>
				Spain
				</li>
				<li>
				Rest of Europe
				</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>
		South America

		<ol>
			<li>
			Introduction
			</li>
			<li>
			Key Region-Specific Dynamics
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

			<ol>
				<li>
				Brazil
				</li>
				<li>
				Argentina
				</li>
				<li>
				Rest of South America
				</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>
		Asia Pacific

		<ol>
			<li>
			Introduction
			</li>
			<li>
			Key Region-Specific Dynamics
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

			<ol>
				<li>
				China
				</li>
				<li>
				India
				</li>
				<li>
				Japan
				</li>
				<li>
				Australia
				</li>
				<li>
				Rest of Asia Pacific
				</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>
		Middle East and Africa

		<ol>
			<li>
			Introduction
			</li>
			<li>
			Key Region-Specific Dynamics
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
			</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	Competitive Landscape

	<ol>
		<li>
		Key Developments and Strategies
		</li>
		<li>
		Company Share Analysis
		</li>
		<li>
		Product Benchmarking
		</li>
		<li>
		List of key companies to watch
		</li>
		<li>
		List of the company with disruptive technology
		</li>
		<li>
		List of start-up companies
		</li>
	</ol>
	</li>
	<li>
	Company Profiles

	<ol>
		<li>
		Sanofi SA *

		<ol>
			<li>
			Company Overview
			</li>
			<li>
			Product Portfolio and Description
			</li>
			<li>
			Key Highlights
			</li>
			<li>
			Financial Overview
			</li>
		</ol>
		</li>
		<li>
		Aceto Corporation
		</li>
		<li>
		&nbsp;BASF SE
		</li>
		<li>
		&nbsp;Chiracon GmbH
		</li>
		<li>
		&nbsp;Yin-sheng Bio-tech Co. Ltd.
		</li>
		<li>
		Dishman Group
		</li>
		<li>
		&nbsp;Green Vision Life Sciences
		</li>
		<li>
		&nbsp;Midas Pharma GmbH
		</li>
		<li>
		Vertellus Holdings LLC
		</li>
		<li>
		&nbsp;Zydus Cadila (*LIST NOT EXHAUSTIVE)
		</li>
	</ol>
	</li>
	<li>
	DataM Intelligence

	<ol>
		<li>
		Appendix
		</li>
		<li>
		About Us and Services
		</li>
		<li>
		Contact Us
		</li>
	</ol>
	</li>
</ol>

List of Tables

Table 01 Global Pharmaceutical Intermediates Market Value, By Type, 2023, 2027 &amp; 2031 ($ Million)

Table 02 Global Pharmaceutical Intermediates Market Value, By Application, 2023, 2027 &amp; 2031 ($ Million)

Table 03 Global Pharmaceutical Intermediates Market Value, By End-User, 2023, 2027 &amp; 2031 ($ Million)

Table 04 Global Pharmaceutical Intermediates Market Value, By Region, 2023, 2027 &amp; 2031 ($ Million)

Table 05 Global Pharmaceutical Intermediates Market Value, By Type, 2023, 2027 &amp; 2031 ($ Million)

Table 06 Global Pharmaceutical Intermediates Market Value, By Type, 2022-2031 ($ Million)

Table 07 Global Pharmaceutical Intermediates Market Value, By Application, 2023, 2027 &amp; 2031 ($ Million)

Table 08 Global Pharmaceutical Intermediates Market Value, By Application, 2022-2031 ($ Million)

Table 10 Global Pharmaceutical Intermediates Market Value, By End-User, 2023, 2027 &amp; 2031 ($ Million)

Table 11 Global Pharmaceutical Intermediates Market Value, By End-User, 2022-2031 ($ Million)

Table 12 Global Pharmaceutical Intermediates Market Value, By Region, 2023, 2027 &amp; 2031 ($ Million)

Table 13 Global Pharmaceutical Intermediates Market Value, By Region, 2022-2031 ($ Million)

Table 14 North America Pharmaceutical Intermediates Market Value, By Type, 2022-2031 ($ Million)

Table 15 North America Pharmaceutical Intermediates Market Value, By Application, 2022-2031 ($ Million)

Table 16 North America Pharmaceutical Intermediates Market Value, By End-User, 2022-2031 ($ Million)

Table 17 North America Pharmaceutical Intermediates Market Value, By Country, 2022-2031 ($ Million)

Table 18 South America Pharmaceutical Intermediates Market Value, By Type, 2022-2031 ($ Million)

Table 19 South America Pharmaceutical Intermediates Market Value, By Application, 2022-2031 ($ Million)

Table 20 South America Pharmaceutical Intermediates Market Value, By End-User, 2022-2031 ($ Million)

Table 21 South America Pharmaceutical Intermediates Market Value, By Country, 2022-2031 ($ Million)

Table 22 Europe Pharmaceutical Intermediates Market Value, By Type, 2022-2031 ($ Million)

Table 23 Europe Pharmaceutical Intermediates Market Value, By Application, 2022-2031 ($ Million)

Table 24 Europe Pharmaceutical Intermediates Market Value, By End-User, 2022-2031 ($ Million)

Table 25 Europe Pharmaceutical Intermediates Market Value, By Country, 2022-2031 ($ Million)

Table 26 Asia-Pacific Pharmaceutical Intermediates Market Value, By Type, 2022-2031 ($ Million)

Table 27 Asia-Pacific Pharmaceutical Intermediates Market Value, By Application, 2022-2031 ($ Million)

Table 28 Asia-Pacific Pharmaceutical Intermediates Market Value, By End-User, 2022-2031 ($ Million)

Table 29 Asia-Pacific Pharmaceutical Intermediates Market Value, By Country, 2022-2031 ($ Million)

Table 30 Middle East &amp; Africa Pharmaceutical Intermediates Market Value, By Type, 2022-2031 ($ Million)

Table 31 Middle East &amp; Africa Pharmaceutical Intermediates Market Value, By Application, 2022-2031 ($ Million)

Table 32 Middle East &amp; Africa Pharmaceutical Intermediates Market Value, By End-User, 2022-2031 ($ Million)

Table 33 Sanofi SA,: Overview

Table 34 Sanofi SA,: Product Portfolio

Table 35 Sanofi SA,: Key Developments

Table 36 Aceto Corporation: Overview

Table 37 Aceto Corporation: Product Portfolio

Table 38 Aceto Corporation: Key Developments

Table 39 BASF SE: Overview

Table 40 BASF SE: Product Portfolio

Table 41 BASF SE: Key Developments

Table 42 Chiracon GmbH: Overview

Table 43 Chiracon GmbH: Product Portfolio

Table 44 Chiracon GmbH: Key Developments

Table 45 Yin-sheng Bio-tech Co.: Overview

Table 46 Yin-sheng Bio-tech Co.: Product Portfolio

Table 47 Yin-sheng Bio-tech Co.: Key Developments

Table 48 Dishman Group: Overview

Table 49 Dishman Group: Product Portfolio

Table 50 Dishman Group: Key Developments

Table 51 Green Vision Life Sciences: Overview

Table 52 Green Vision Life Sciences: Product Portfolio

Table 53 Green Vision Life Sciences: Key Developments

Table 54 Midas Pharma GmbH: Overview

Table 55 Midas Pharma GmbH: Product Portfolio

Table 56 Midas Pharma GmbH: Key Developments

Table 57 Vertellus Holdings LLC. : Overview

Table 58 Vertellus Holdings LLC. : Product Portfolio

Table 59 Vertellus Holdings LLC. : Key Developments

Table 60 Zydus Cadila: Overview

Table 61 Zydus Cadila: Product Portfolio

Table 62 Zydus Cadila: Key Developments

&nbsp;

List of Figures

Figure 01 Global Pharmaceutical Intermediates Market Share, By Type, 2022 &amp; 2031 (%)

Figure 02 Global Pharmaceutical Intermediates Market Share, By Application, 2022 &amp; 2031 (%)

Figure 03 Global Pharmaceutical Intermediates Market Share, By End-User, 2022 &amp; 2031 (%)

Figure 04 Global Pharmaceutical Intermediates Market Share, By Region, 2022 &amp; 2031 (%)

Figure 05 Global Pharmaceutical Intermediates Market Value, 2022-2031 ($ Million)

Figure 06 Global Pharmaceutical Intermediates Market Y-o-Y Growth, By Type, 2022-2031 (%)

Figure 07 Chemical Intermediate: Global Pharmaceutical Intermediates Market Value, 2022-2031 ($ Million)

Figure 08 Bulk Drug Intermediate: Global Pharmaceutical Intermediates Market Value, 2022-2031 ($ Million)

Figure 09 Custom Intermediates: Global Pharmaceutical Intermediates Market Value, 2022-2031 ($ Million)

Figure 10 Others: Global Pharmaceutical Intermediates Market Value, 2022-2031 ($ Million)

Figure 11 Global Pharmaceutical Intermediates Market Y-o-Y Growth, By Application, 2022-2031 (%)

Figure 12 Analgesics: Global Pharmaceutical Intermediates Market Value, 2022-2031 ($ Million)

Figure 13 Anti-Infective Drugs: Global Pharmaceutical Intermediates Market Value, 2022-2031 ($ Million)

Figure 14 Cardiovascular Drugs: Global Pharmaceutical Intermediates Market Value, 2022-2031 ($ Million)

Figure 15 Oral Antidiabetic Drugs: Global Pharmaceutical Intermediates Market Value, 2022-2031 ($ Million)

Figure 16 Antimicrobial Drugs: Global Pharmaceutical Intermediates Market Value, 2022-2031 ($ Million)

Figure 17 &quot;Others: Global Pharmaceutical Intermediates Market Value, 2022-2031 ($ Million)&quot;

Figure 18 Global Pharmaceutical Intermediates Market Y-o-Y Growth, By End-User, 2022-2031 (%)

Figure 19 Biotech and Pharma Companies: Global Pharmaceutical Intermediates Market Value, 2022-2031 ($ Million)

Figure 20 Research Institutions: Global Pharmaceutical Intermediates Market Value, 2022-2031 ($ Million)

Figure 21 Contract manufacturing organizations: Global Pharmaceutical Intermediates Market Value, 2022-2031 ($ Million)

Figure 22 Others: Global Pharmaceutical Intermediates Market Value, 2022-2031 ($ Million)

Figure 23 Global Pharmaceutical Intermediates Market Y-o-Y Growth, By Region, 2022-2031 (%)

Figure 24 North America Pharmaceutical Intermediates Market Value, 2022-2031 ($ Million)

Figure 25 North America Pharmaceutical Intermediates Market Share, By Type, 2022 &amp; 2031 (%)

Figure 26 North America Pharmaceutical Intermediates Market Share, By Application, 2022 &amp; 2031 (%)

Figure 27 North America Pharmaceutical Intermediates Market Share, By End-User, 2022 &amp; 2031 (%)

Figure 28 North America Pharmaceutical Intermediates Market Share, By Country, 2022 &amp; 2031 (%)

Figure 29 South America Pharmaceutical Intermediates Market Value, 2022-2031 ($ Million)

Figure 30 South America Pharmaceutical Intermediates Market Share, By Type, 2022 &amp; 2031 (%)

Figure 31 South America Pharmaceutical Intermediates Market Share, By Application, 2022 &amp; 2031 (%)

Figure 32 South America Pharmaceutical Intermediates Market Share, By End-User, 2022 &amp; 2031 (%)

Figure 33 South America Pharmaceutical Intermediates Market Share, By Country, 2022 &amp; 2031 (%)

Figure 34 Europe Pharmaceutical Intermediates Market Value, 2022-2031 ($ Million)

Figure 35 Europe Pharmaceutical Intermediates Market Share, By Type, 2022 &amp; 2031 (%)

Figure 36 Europe Pharmaceutical Intermediates Market Share, By Application, 2022 &amp; 2031 (%)

Figure 37 Europe Pharmaceutical Intermediates Market Share, By End-User, 2022 &amp; 2031 (%)

Figure 38 Europe Pharmaceutical Intermediates Market Share, By Country, 2022 &amp; 2031 (%)

Figure 39 Asia-Pacific Pharmaceutical Intermediates Market Value, 2022-2031 ($ Million)

Figure 40 Asia-Pacific Pharmaceutical Intermediates Market Share, By Type, 2022 &amp; 2031 (%)

Figure 41 Asia-Pacific Pharmaceutical Intermediates Market Share, By Application, 2022 &amp; 2031 (%)

Figure 42 Asia-Pacific Pharmaceutical Intermediates Market Share, By End-User, 2022 &amp; 2031 (%)

Figure 43 Asia-Pacific Pharmaceutical Intermediates Market Share, By Country, 2022 &amp; 2031 (%)

Figure 44 Middle East &amp; Africa Pharmaceutical Intermediates Market Value, 2022-2031 ($ Million)

Figure 45 Middle East &amp; Africa Pharmaceutical Intermediates Market Share, By Type, 2022 &amp; 2031 (%)

Figure 46 Middle East &amp; Africa Pharmaceutical Intermediates Market Share, By Application, 2022 &amp; 2031 (%)

Figure 47 Middle East &amp; Africa Pharmaceutical Intermediates Market Share, By End-User, 2022 &amp; 2031 (%)

Figure 48 Middle East &amp; Africa Pharmaceutical Intermediates Market Share, By 0, 2022 &amp; 2031 (%)

Figure 49 Sanofi SA,: Financials

Figure 50 Aceto Corporation: Financials

Figure 51 BASF SE: Financials

Figure 52 Chiracon GmbH: Financials

Figure 53 Yin-sheng Bio-tech Co.: Financials

Figure 54 Dishman Group: Financials

Figure 55 Green Vision Life Sciences: Financials

Figure 56 Midas Pharma GmbH: Financials

Figure 57 Vertellus Holdings LLC. : Financials

Figure 58 Zydus Cadila: Financials

Pharmaceutical Intermediates Market Size, Share, Industry, Forecast and outlook (2024-2031)

Pharmaceutical Dispersers Market Size, Share, Industry, Forecast and Outlook (2023-2030)

Published: 2024 January 03

Starting from

Pharmaceutical Filtration Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 January 11

Starting from

Pharmaceutical Cartridges Market Size, Share, Industry, Forecast and Outlook (2024-2031)

Published: 2024 January 04

Starting from